Skip to main content

THOR INVESTMENT MANAGEMENT INC /OH/ /ADV

Position in GILD — Gilead Sciences, Inc.

CIK 883734 CINCINNATI, OH

Position in GILD

as of Jun 30, 2026 · filed Jul 23, 2026
Position Value
$2,900,261
-$335,631 QoQ
Shares Held
22,956
-1.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.82%
of 13F equity value
Holder Rank
#725
of 2,266 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Derivatives in GILD

reported options exposure · as of Dec 31, 2025
CallValue
$36,822
CallShares
300
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

THOR INVESTMENT MANAGEMENT INC /OH/ /ADV holds $10,964,231 across 3 Drug Manufacturers - General names. GILD ranks #2 (26.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 GILD
Gilead Sciences, Inc.
This page
22,956 $2,900,261

All Filings in GILD

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,900,261 22,956
2026-03-31 $3,235,892 23,218
2025-12-31 $36,822 300
2025-12-31 $6,390,949 52,069
2025-09-30 $5,797,086 52,226
2025-09-30 $33,300 300
2025-06-30 $33,261 300
2025-06-30 $5,814,022 52,440
2025-03-31 $5,850,242 52,211
2025-03-31 $44,820 400
2024-12-31 $36,948 400
2024-12-31 $4,841,573 52,415
2024-09-30 $4,333,689 51,690
2024-09-30 $33,536 400
2024-06-30 $27,444 400
2024-06-30 $3,425,217 49,923
2024-03-31 $3,450,661 47,108
2023-12-31 $3,678,340 45,406